Risk of Elevated Blood Glucose Levels in Tuberculosis Patients with BTA 3+ Levels, Puskesmas Bojong Gede Kabupaten Bogor

Febrial Hikmah

Abstract


Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. TB cases are still high that has attracted many researchers to conduct studies, especially the factors that cause therapy failure. TB patients who undergo therapy will be at risk of experiencing changes in carbohydrate metabolism. This is compounded by the condition of patients who have a history of diabetes mellitus (DM) before. Therefore, examination of blood glucose in TB patients is considered necessary to be a series in therapy. The increased risk was also influenced by several factors, including age and gender. The data was taken cross sectional as many as 57 samples of TB patients with various AFB positivity levels. The results obtained that 75% of TB patients included in the positive category 3 AFB, 46% aged >40 years, and 61% were male. Mean blood glucose level of 165 ± 14 mg/dL. About 19% of patients have glucose levels >200 mg/dL. Of the 19% of these patients 91% of patients were in the BTA positive category 3, 91% were aged >40 years and 73% were male. The conclusion is that there is a risk of an increase in blood glucose levels in TB patients with level 3+ AFB.

Full Text:

PDF

References


Abdallah TM, Ali AAA. (2012). Epidemiology of tuberculosis in Eastern Sudan. Asian Pacific Journal of Tropical Biomedicine, 2(12), 999-1001.

Angel GS. (2019). Gambar kadar gula darah pada penderita tuberculosis rawat jalan di rumah sakit khusus paru Medan (Skripsi). Politeknik Kesehatan Kemenkes RI, Medan.

Anthonia OO, et. al. (2015). Clinical profile of diabetes mellitus in tuberculosis. BMJOpen Diabetes Research and Care, 3, 1-6.

Badan Penelitian dan Pengembangan Kesehatan, Kementrian

Kesehatan RI (BPPK-KKRI). (2008). Laporan hasil riset kesehatan dasar (Riskesdas) 2007. Jakarta: Kementrian Kesehatan RI, Jakarta.

Badan Penelitian dan Pengembangan Kesehatan, Kementrian Kesehatan RI (BPPK-KKRI). (2013). Laporan hasil riset kesehatan dasar (Riskesdas) 2013. Jakarta: Kementrian Kesehatan RI, Jakarta.

Bates MN, et. al. (2007). Risk of tuberculosis from exposure to tobacco smoke. Arch. Intern. Med., 167(4), 335-342.

Dooley KE, Tang T, Golub JE, Dorman SE, CroninW. (2009). Impact of diabetes mellitus ontreatment out come so patients with active tuberkulosis. Am J Trop Med Hyg, 80, 634-639.

El-Sony A, Enarson D, Khamis A, Baraka O, Bjune G. (2002). Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int J Tuberc Lung Dis., 6(2), 91–97.

Emma N, Zata I, Pariyana. (2018). Angka kejadian diabetes melitus pada pasien tuberculosis. JKK, 5(1), 20-25.

Fatmah. (2006). Respons imunitas yang rendah pada tubuh manusia usia lanjut. Makara Kesehatan, 10, 47-53.

Heri S, Marumi WD, Iswari F. (2017). Studi kadar glukosa darah sewaktu pada pasien TBC pemakai obat anti tuberculosis (OAT) paket di Puskesmas Cakranegara. Jurnal Analis Medika Bio Sains, 4(1), 52-56.

Hussain M, Hussain S. (2007). Tuberculosis and diabetes mellitus impact of co-association. Pak J Chest Med., 13(4), 24-25.

Jayakody W, et. al. (2013). Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka. PHA, 3(1), 26–30.

Kementerian Kesehatan Republik Indonesia. (2017). Data dan informasi profil kesehatan Indonesia 2017. Jakarta.

Nainggolan HRN. (2013). Faktor yang berhubungan dengan gagal konversi pasien Tb paru kategori I pada akhir pengobatan fase intensif di kota Medan [Tesis]. Medan: Universitas Sumatera Utara.

Peleg AY, Weerarathna T, McCarthy JS, Davis TME. (2007). Common infection in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev, 22(1), 3-13.

Restrepo BI et. al. (2011). Crossectional assessment reveals high diabetes prevalence among newly diagnosed tuberculosis cases. Bulletin of the World Health Organization. 89: 352-359.

Sen T, Joshi SR, Udwadia ZF. (2009). Tuberculosis and diabetes mellitus: merging epidemics. JAPI, 57, 399-420.

Soemantri S, et. al. (2007). Three-fold reduction in the prevalence of tuberculosis over 25 years in Indonesia. Int J Tuberc Lung Dis., 11(4), 398–404.

Suharyati S, Widiyanto YD. (2019). Kadar glukosa darah penderita tuberculosis paru dengan bakteri tahan asam positif. Jaringan Laboratorium Medis, 1(1), 42-45.

World Health Organization (WHO). (2018). Global tuberculosis report. Geneva. Available from: http://www.who.int/tb/publication/global_report/en/.




DOI: https://doi.org/10.32807/jambs.v7i2.189

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Jurnal Analis Medika Biosains (JAMBS)

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 


Jurnal Analis Medika Biosains (JAMBS) Poltekkes Kemenkes Mataram, Jurusan Analis Kesehatan
Jl. Praburangkasari, Dasan Cermen, Sandubaya, Mataram.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.